Mayer B. Davidson, MD
To the editor: In the 15 October issue, Singer and colleagues recommend that patients not be screened for type 2 diabetes. They argue that there is no convincing evidence that therapy can ameliorate or prevent chronic complications and that therapy begun when the patient is asymptomatic is no more effective than therapy begun after diabetes causes symptoms.
We need to address the questions of complications and control more critically than simply referring to the (largely discredited) University Group Diabetes Program study: "Complications" need to be separated into those that are macrovascular, for which the evidence is poor that glucose control
Davidson MB. Screening for Diabetes Mellitus. Ann Intern Med. ;110:168. doi: 10.7326/0003-4819-110-2-168_1
Download citation file:
Published: Ann Intern Med. 1989;110(2):168.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use